
Opinion|Videos|May 6, 2024
Patient Subgroups With a Higher Prevalence of Hypercortisolism
The panel emphasizes the importance of early identification of patients based on subgroups, such as those with difficult-to-control diabetes, hypertension, and bone issues, highlighting that the inability to lower a patient's insulin dosage is a significant risk factor for hypercortisolism.
Advertisement
Episodes in this series

Advertisement
Advertisement
Advertisement
Trending on HCPLive
1
ALOFT-IPF: Admilparant 60 mg Meets Primary FVC End Point
2
Resmetirom Tied to Lower MACE vs Semaglutide in Real-World MASLD Analysis
3
Long-Term Risankizumab Data Show Durable Crohn’s, Fistula Outcomes
4
Eplontersen Fails to Achieve Primary Endpoint, Improves KCCQ and 6MWT in ATTR-CM
5


